A New Refractory Multiple Myeloma Treatment: SUCCESSOR-2 trial Multiple Myeloma 12 Mins Read76 Refractory multiple myeloma remains a significant challenge in the field of oncology, necessitating innovative therapeutic strategies. Mezigdomide, a novel oral…
